RSSDI endorses the IDF Position Statement on 1 h post load plasma glucose for diagnosis of intermediate hyperglycemia and type 2 diabetes

The Oral Glucose Tolerance Test (OGTT) remains a gold standard for diagnosis of diabetes and prediabetes all over the world and also in India. The original OGTT was a five sample test which included fasting, 30, 60, 90, and 120 min. Later, the test was modified in the US to two sample test 0 and 120...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of diabetes in developing countries 2024-06, Vol.44 (2), p.216-219
Hauptverfasser: Sahay, Rakesh, Mohan, Viswanathan, Agarwal, Sanjay, Saboo, Banshi, Ghosh, Sujoy, Murthy, L. Sreenivasa, Unnikrishnan, Ambika Gopalakrishnan, Kapoor, Nitin, Gupta, Arvind, Bhandari, Sudhir, Jethwani, Pratap, Chawla, Manoj, Sharma, J. K., Kumar, Anshul, Jaggi, Shalini, Chawla, Rajeev, Viswanathan, Vijay, Makkar, B. M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 219
container_issue 2
container_start_page 216
container_title International journal of diabetes in developing countries
container_volume 44
creator Sahay, Rakesh
Mohan, Viswanathan
Agarwal, Sanjay
Saboo, Banshi
Ghosh, Sujoy
Murthy, L. Sreenivasa
Unnikrishnan, Ambika Gopalakrishnan
Kapoor, Nitin
Gupta, Arvind
Bhandari, Sudhir
Jethwani, Pratap
Chawla, Manoj
Sharma, J. K.
Kumar, Anshul
Jaggi, Shalini
Chawla, Rajeev
Viswanathan, Vijay
Makkar, B. M.
description The Oral Glucose Tolerance Test (OGTT) remains a gold standard for diagnosis of diabetes and prediabetes all over the world and also in India. The original OGTT was a five sample test which included fasting, 30, 60, 90, and 120 min. Later, the test was modified in the US to two sample test 0 and 120 min, i.e., fasting and 2 h after 75 g glucose and this has been in practice all over the world. Traditional diabetologists continue to measure some of the intermediate samples, particularly the 60 min or 1 h value which identifies individuals even before the fasting or 2 h value becomes abnormal. Thus, even before the stage of prediabetes when one has a normal fasting and 2 h value, a raised 1 h value above 155 mg/dl has been shown to predict who will progress to diabetes. A group of 22 international experts recently got together and the IDF Position Statement on the 1 h value was published which shows why the 1 h value in the OGTT should be reintroduced in the routine lab testing of OGTT. This article is an endorsement of the IDF Position Statement on the 1 h value. Introducing the 1 h value in the OGTT is particularly relevant to India which has one of the fastest conversions of prediabetes to diabetes and also a very rapid loss of beta cell function. Identifying early stages of intermediate hyperglycemia can help to prevent diabetes and also reverse the condition.
doi_str_mv 10.1007/s13410-024-01345-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3055503284</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3055503284</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-aa0c6e65be0e110f83e65a7936a969dcd1b2602e6215c12df5e5bbd384bfea483</originalsourceid><addsrcrecordid>eNp9kEtOwzAQhi0EEqVwAVYjsQ6M7SRNlqjlUakSiMLacpJJmyqJg-0uegVOwVk4GS5FYsdqHvq_Gelj7JLjNUec3DguY44RijjC0CYRP2IjnudZJDMpjtkI84mMZC7xlJ05t0FMEpHKEft4WS5nc6C-MtaRA78mmM_u4dm4xjemh6XXnjrqPYSBf32uYTDOQ2t0BUOrXadh1W5L4whqY6Fq9KoPrANTQ9N7sh2FnSdY7wayq3ZXUtdo0H0FPmxA7JGCPLlzdlLr1tHFbx2zt_u71-ljtHh6mE9vF1EpJugjrbFMKU0KQuIc60yGQU9ymeo8zauy4oVIUVAqeFJyUdUJJUVRySwuatJxJsfs6nB3sOZ9S86rjdnaPrxUMmhJUIosDilxSJXWOGepVoNtOm13iqPaO1cH5yo4Vz_OFQ-QPEAuhPsV2b_T_1DfugmGaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3055503284</pqid></control><display><type>article</type><title>RSSDI endorses the IDF Position Statement on 1 h post load plasma glucose for diagnosis of intermediate hyperglycemia and type 2 diabetes</title><source>SpringerLink Journals - AutoHoldings</source><creator>Sahay, Rakesh ; Mohan, Viswanathan ; Agarwal, Sanjay ; Saboo, Banshi ; Ghosh, Sujoy ; Murthy, L. Sreenivasa ; Unnikrishnan, Ambika Gopalakrishnan ; Kapoor, Nitin ; Gupta, Arvind ; Bhandari, Sudhir ; Jethwani, Pratap ; Chawla, Manoj ; Sharma, J. K. ; Kumar, Anshul ; Jaggi, Shalini ; Chawla, Rajeev ; Viswanathan, Vijay ; Makkar, B. M.</creator><creatorcontrib>Sahay, Rakesh ; Mohan, Viswanathan ; Agarwal, Sanjay ; Saboo, Banshi ; Ghosh, Sujoy ; Murthy, L. Sreenivasa ; Unnikrishnan, Ambika Gopalakrishnan ; Kapoor, Nitin ; Gupta, Arvind ; Bhandari, Sudhir ; Jethwani, Pratap ; Chawla, Manoj ; Sharma, J. K. ; Kumar, Anshul ; Jaggi, Shalini ; Chawla, Rajeev ; Viswanathan, Vijay ; Makkar, B. M.</creatorcontrib><description>The Oral Glucose Tolerance Test (OGTT) remains a gold standard for diagnosis of diabetes and prediabetes all over the world and also in India. The original OGTT was a five sample test which included fasting, 30, 60, 90, and 120 min. Later, the test was modified in the US to two sample test 0 and 120 min, i.e., fasting and 2 h after 75 g glucose and this has been in practice all over the world. Traditional diabetologists continue to measure some of the intermediate samples, particularly the 60 min or 1 h value which identifies individuals even before the fasting or 2 h value becomes abnormal. Thus, even before the stage of prediabetes when one has a normal fasting and 2 h value, a raised 1 h value above 155 mg/dl has been shown to predict who will progress to diabetes. A group of 22 international experts recently got together and the IDF Position Statement on the 1 h value was published which shows why the 1 h value in the OGTT should be reintroduced in the routine lab testing of OGTT. This article is an endorsement of the IDF Position Statement on the 1 h value. Introducing the 1 h value in the OGTT is particularly relevant to India which has one of the fastest conversions of prediabetes to diabetes and also a very rapid loss of beta cell function. Identifying early stages of intermediate hyperglycemia can help to prevent diabetes and also reverse the condition.</description><identifier>ISSN: 0973-3930</identifier><identifier>EISSN: 1998-3832</identifier><identifier>DOI: 10.1007/s13410-024-01345-1</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Beta cells ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; Diagnosis ; Endorsements ; Family Medicine ; Fasting ; General Practice ; Glucose ; Glucose tolerance ; Health Administration ; Hyperglycemia ; Laboratory testing ; Medical diagnosis ; Medicine ; Medicine &amp; Public Health ; Review Article</subject><ispartof>International journal of diabetes in developing countries, 2024-06, Vol.44 (2), p.216-219</ispartof><rights>The Author(s), under exclusive licence to Research Society for Study of Diabetes in India 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-aa0c6e65be0e110f83e65a7936a969dcd1b2602e6215c12df5e5bbd384bfea483</cites><orcidid>0000-0001-5038-6210</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13410-024-01345-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s13410-024-01345-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Sahay, Rakesh</creatorcontrib><creatorcontrib>Mohan, Viswanathan</creatorcontrib><creatorcontrib>Agarwal, Sanjay</creatorcontrib><creatorcontrib>Saboo, Banshi</creatorcontrib><creatorcontrib>Ghosh, Sujoy</creatorcontrib><creatorcontrib>Murthy, L. Sreenivasa</creatorcontrib><creatorcontrib>Unnikrishnan, Ambika Gopalakrishnan</creatorcontrib><creatorcontrib>Kapoor, Nitin</creatorcontrib><creatorcontrib>Gupta, Arvind</creatorcontrib><creatorcontrib>Bhandari, Sudhir</creatorcontrib><creatorcontrib>Jethwani, Pratap</creatorcontrib><creatorcontrib>Chawla, Manoj</creatorcontrib><creatorcontrib>Sharma, J. K.</creatorcontrib><creatorcontrib>Kumar, Anshul</creatorcontrib><creatorcontrib>Jaggi, Shalini</creatorcontrib><creatorcontrib>Chawla, Rajeev</creatorcontrib><creatorcontrib>Viswanathan, Vijay</creatorcontrib><creatorcontrib>Makkar, B. M.</creatorcontrib><title>RSSDI endorses the IDF Position Statement on 1 h post load plasma glucose for diagnosis of intermediate hyperglycemia and type 2 diabetes</title><title>International journal of diabetes in developing countries</title><addtitle>Int J Diabetes Dev Ctries</addtitle><description>The Oral Glucose Tolerance Test (OGTT) remains a gold standard for diagnosis of diabetes and prediabetes all over the world and also in India. The original OGTT was a five sample test which included fasting, 30, 60, 90, and 120 min. Later, the test was modified in the US to two sample test 0 and 120 min, i.e., fasting and 2 h after 75 g glucose and this has been in practice all over the world. Traditional diabetologists continue to measure some of the intermediate samples, particularly the 60 min or 1 h value which identifies individuals even before the fasting or 2 h value becomes abnormal. Thus, even before the stage of prediabetes when one has a normal fasting and 2 h value, a raised 1 h value above 155 mg/dl has been shown to predict who will progress to diabetes. A group of 22 international experts recently got together and the IDF Position Statement on the 1 h value was published which shows why the 1 h value in the OGTT should be reintroduced in the routine lab testing of OGTT. This article is an endorsement of the IDF Position Statement on the 1 h value. Introducing the 1 h value in the OGTT is particularly relevant to India which has one of the fastest conversions of prediabetes to diabetes and also a very rapid loss of beta cell function. Identifying early stages of intermediate hyperglycemia can help to prevent diabetes and also reverse the condition.</description><subject>Beta cells</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diagnosis</subject><subject>Endorsements</subject><subject>Family Medicine</subject><subject>Fasting</subject><subject>General Practice</subject><subject>Glucose</subject><subject>Glucose tolerance</subject><subject>Health Administration</subject><subject>Hyperglycemia</subject><subject>Laboratory testing</subject><subject>Medical diagnosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Review Article</subject><issn>0973-3930</issn><issn>1998-3832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kEtOwzAQhi0EEqVwAVYjsQ6M7SRNlqjlUakSiMLacpJJmyqJg-0uegVOwVk4GS5FYsdqHvq_Gelj7JLjNUec3DguY44RijjC0CYRP2IjnudZJDMpjtkI84mMZC7xlJ05t0FMEpHKEft4WS5nc6C-MtaRA78mmM_u4dm4xjemh6XXnjrqPYSBf32uYTDOQ2t0BUOrXadh1W5L4whqY6Fq9KoPrANTQ9N7sh2FnSdY7wayq3ZXUtdo0H0FPmxA7JGCPLlzdlLr1tHFbx2zt_u71-ljtHh6mE9vF1EpJugjrbFMKU0KQuIc60yGQU9ymeo8zauy4oVIUVAqeFJyUdUJJUVRySwuatJxJsfs6nB3sOZ9S86rjdnaPrxUMmhJUIosDilxSJXWOGepVoNtOm13iqPaO1cH5yo4Vz_OFQ-QPEAuhPsV2b_T_1DfugmGaA</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Sahay, Rakesh</creator><creator>Mohan, Viswanathan</creator><creator>Agarwal, Sanjay</creator><creator>Saboo, Banshi</creator><creator>Ghosh, Sujoy</creator><creator>Murthy, L. Sreenivasa</creator><creator>Unnikrishnan, Ambika Gopalakrishnan</creator><creator>Kapoor, Nitin</creator><creator>Gupta, Arvind</creator><creator>Bhandari, Sudhir</creator><creator>Jethwani, Pratap</creator><creator>Chawla, Manoj</creator><creator>Sharma, J. K.</creator><creator>Kumar, Anshul</creator><creator>Jaggi, Shalini</creator><creator>Chawla, Rajeev</creator><creator>Viswanathan, Vijay</creator><creator>Makkar, B. M.</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><orcidid>https://orcid.org/0000-0001-5038-6210</orcidid></search><sort><creationdate>20240601</creationdate><title>RSSDI endorses the IDF Position Statement on 1 h post load plasma glucose for diagnosis of intermediate hyperglycemia and type 2 diabetes</title><author>Sahay, Rakesh ; Mohan, Viswanathan ; Agarwal, Sanjay ; Saboo, Banshi ; Ghosh, Sujoy ; Murthy, L. Sreenivasa ; Unnikrishnan, Ambika Gopalakrishnan ; Kapoor, Nitin ; Gupta, Arvind ; Bhandari, Sudhir ; Jethwani, Pratap ; Chawla, Manoj ; Sharma, J. K. ; Kumar, Anshul ; Jaggi, Shalini ; Chawla, Rajeev ; Viswanathan, Vijay ; Makkar, B. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-aa0c6e65be0e110f83e65a7936a969dcd1b2602e6215c12df5e5bbd384bfea483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Beta cells</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diagnosis</topic><topic>Endorsements</topic><topic>Family Medicine</topic><topic>Fasting</topic><topic>General Practice</topic><topic>Glucose</topic><topic>Glucose tolerance</topic><topic>Health Administration</topic><topic>Hyperglycemia</topic><topic>Laboratory testing</topic><topic>Medical diagnosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sahay, Rakesh</creatorcontrib><creatorcontrib>Mohan, Viswanathan</creatorcontrib><creatorcontrib>Agarwal, Sanjay</creatorcontrib><creatorcontrib>Saboo, Banshi</creatorcontrib><creatorcontrib>Ghosh, Sujoy</creatorcontrib><creatorcontrib>Murthy, L. Sreenivasa</creatorcontrib><creatorcontrib>Unnikrishnan, Ambika Gopalakrishnan</creatorcontrib><creatorcontrib>Kapoor, Nitin</creatorcontrib><creatorcontrib>Gupta, Arvind</creatorcontrib><creatorcontrib>Bhandari, Sudhir</creatorcontrib><creatorcontrib>Jethwani, Pratap</creatorcontrib><creatorcontrib>Chawla, Manoj</creatorcontrib><creatorcontrib>Sharma, J. K.</creatorcontrib><creatorcontrib>Kumar, Anshul</creatorcontrib><creatorcontrib>Jaggi, Shalini</creatorcontrib><creatorcontrib>Chawla, Rajeev</creatorcontrib><creatorcontrib>Viswanathan, Vijay</creatorcontrib><creatorcontrib>Makkar, B. M.</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>International journal of diabetes in developing countries</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sahay, Rakesh</au><au>Mohan, Viswanathan</au><au>Agarwal, Sanjay</au><au>Saboo, Banshi</au><au>Ghosh, Sujoy</au><au>Murthy, L. Sreenivasa</au><au>Unnikrishnan, Ambika Gopalakrishnan</au><au>Kapoor, Nitin</au><au>Gupta, Arvind</au><au>Bhandari, Sudhir</au><au>Jethwani, Pratap</au><au>Chawla, Manoj</au><au>Sharma, J. K.</au><au>Kumar, Anshul</au><au>Jaggi, Shalini</au><au>Chawla, Rajeev</au><au>Viswanathan, Vijay</au><au>Makkar, B. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RSSDI endorses the IDF Position Statement on 1 h post load plasma glucose for diagnosis of intermediate hyperglycemia and type 2 diabetes</atitle><jtitle>International journal of diabetes in developing countries</jtitle><stitle>Int J Diabetes Dev Ctries</stitle><date>2024-06-01</date><risdate>2024</risdate><volume>44</volume><issue>2</issue><spage>216</spage><epage>219</epage><pages>216-219</pages><issn>0973-3930</issn><eissn>1998-3832</eissn><abstract>The Oral Glucose Tolerance Test (OGTT) remains a gold standard for diagnosis of diabetes and prediabetes all over the world and also in India. The original OGTT was a five sample test which included fasting, 30, 60, 90, and 120 min. Later, the test was modified in the US to two sample test 0 and 120 min, i.e., fasting and 2 h after 75 g glucose and this has been in practice all over the world. Traditional diabetologists continue to measure some of the intermediate samples, particularly the 60 min or 1 h value which identifies individuals even before the fasting or 2 h value becomes abnormal. Thus, even before the stage of prediabetes when one has a normal fasting and 2 h value, a raised 1 h value above 155 mg/dl has been shown to predict who will progress to diabetes. A group of 22 international experts recently got together and the IDF Position Statement on the 1 h value was published which shows why the 1 h value in the OGTT should be reintroduced in the routine lab testing of OGTT. This article is an endorsement of the IDF Position Statement on the 1 h value. Introducing the 1 h value in the OGTT is particularly relevant to India which has one of the fastest conversions of prediabetes to diabetes and also a very rapid loss of beta cell function. Identifying early stages of intermediate hyperglycemia can help to prevent diabetes and also reverse the condition.</abstract><cop>New Delhi</cop><pub>Springer India</pub><doi>10.1007/s13410-024-01345-1</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-5038-6210</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0973-3930
ispartof International journal of diabetes in developing countries, 2024-06, Vol.44 (2), p.216-219
issn 0973-3930
1998-3832
language eng
recordid cdi_proquest_journals_3055503284
source SpringerLink Journals - AutoHoldings
subjects Beta cells
Diabetes
Diabetes mellitus (non-insulin dependent)
Diagnosis
Endorsements
Family Medicine
Fasting
General Practice
Glucose
Glucose tolerance
Health Administration
Hyperglycemia
Laboratory testing
Medical diagnosis
Medicine
Medicine & Public Health
Review Article
title RSSDI endorses the IDF Position Statement on 1 h post load plasma glucose for diagnosis of intermediate hyperglycemia and type 2 diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A18%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RSSDI%20endorses%20the%20IDF%20Position%20Statement%20on%201%C2%A0h%20post%20load%20plasma%20glucose%20for%20diagnosis%20of%20intermediate%20hyperglycemia%20and%20type%202%20diabetes&rft.jtitle=International%20journal%20of%20diabetes%20in%20developing%20countries&rft.au=Sahay,%20Rakesh&rft.date=2024-06-01&rft.volume=44&rft.issue=2&rft.spage=216&rft.epage=219&rft.pages=216-219&rft.issn=0973-3930&rft.eissn=1998-3832&rft_id=info:doi/10.1007/s13410-024-01345-1&rft_dat=%3Cproquest_cross%3E3055503284%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3055503284&rft_id=info:pmid/&rfr_iscdi=true